These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5.
    Author: Stefanutti C, Notarbartolo A, Colloridi V, Nigri A, Vivenzio A, Bertolini S, Bosco G, Berni A, Di Giacomo S, Mazzarella B.
    Journal: Artif Organs; 1997 Oct; 21(10):1126-7. PubMed ID: 9335372.
    Abstract:
    Preliminary experience with the efficacy and safety of dextran sulfate cellulose low-density lipoprotein (LDL) apheresis for the treatment of a 4.5-year-old girl with homozygous familial hypercholesterolemia and coronary artery disease is reported. The decrease of the most atherogenic apolipoprotein B-containing lipoproteins, low-density lipoprotein (LDL) and lipoprotein(a) (Lp [a]), were in the ranges of 63.1-68.7%, and 52.5-58.6%, respectively. The child tolerated LDL apheresis without any clinically significant complications. Therefore, she was submitted to a long-term program of treatment at intervals of 15 days. The experience suggests the possibility of an early beginning of extracorporeal treatment with LDL apheresis in children severely affected by homozygous or double heterozygous familial hypercholesterolemia.
    [Abstract] [Full Text] [Related] [New Search]